The Bloomberg-backed cybersecurity technology developer reeled in $26m in a round co-led by Sorenson Ventures, Lytical Ventures and Edison Partners.
Author: Jack Hammond
Hearst makes Plum investment
Hearst Ventures was among the participants in a round that will fund the roll-out of Plum Guide’s high-end holiday accommodation rental platform to 12 more cities.
OptiScan scoops up $20m
The Mitsui-backed glucose monitoring technology provider will use the series E proceeds to fund the commercialisation of its device in the US.
Tidesquare books in corporates for funding
The online travel booking platform has collected $44.3m in a round featuring Dunamu as well as a reported $30.7m investment from Kakao.
Abbisko sticks series B landing to raise $42m
The CNPG-backed oncology therapy developer boosted its overall funding to $70m in a round backed by Eli Lilly and CICC Capital.
Imago marks series B round with $40m
Amgen Ventures, MRL Ventures Fund and Pharmaron contributed to a round that almost doubled the total raised by the bone marrow disease drug developer since 2012.
WorkBoard chalks up $23m in series B
Workday joined existing investor Microsoft in a round that will support the development of WorkBoard’s enterprise planning software, taking its total funding to $35m.
HoneyBook folds in $28m
The Citi Ventures-led round increased the total raised by the freelance business and financial planning service to $60m in the past five years.
MX Federation adds Bertelsmann to series C1 mix
GLP-backed BitRock Capital has led an eight-figure dollar round for the digital wealth management platform that also featured existing backer BAI.
Severstal steels itself with new accelerator
Severstal has launched an accelerator to develop metallurgical technology startups as part of a $25m open innovation investment drive.
Hesus ascends with corporate funding
Bouygues Construction and Suez Group have both contributed to an $11.3m round that will fund the construction waste removal service’s European expansion.
Carbon Engineering unearths $68m
Chevron, Occidental Petroleum, BHP and Bethel Lands all invested in a round that will fund further testing of Carbon Enginnering’s carbon capture technology.
Pfizer visits Vivet with $51m
Pharmaceutical firm Pfizer has acquired a 15% stake in the gene therapy developer along with an exclusive option to fully buy the Novartis-backed company.
Movius dials in $45m series D
The communication software developer boosted its total funding to $91m in a round that included Anschutz Investment Company.